⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15415862 | 0.83 | — | — | |
| SCHEMBL15415845 | 0.70 | — | — | |
| SCHEMBL15416470 | 0.70 | — | — | |
| SCHEMBL2777128 | 0.70 | — | — | |
| SCHEMBL7090604 | 0.67 | — | — | |
| SCHEMBL3054233 | 0.65 | — | — | |
| SCHEMBL3240865 | 0.61 | — | — | |
| SCHEMBL15416702 | 0.59 | — | — | |
| SCHEMBL10477888 | 0.57 | — | — | |
| SCHEMBL5552302 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3021860-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | Leptrex Ltd. (GB) | 2016-05-25 | — | — | EP | claimed |
| WO-2015008019-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2015-01-22 | — | — | WO | claimed |
| WO-2014009759-A2 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2014-01-16 | — | — | WO | claimed |
| US-9707201-B2 | Allium extracts | LEPTREX LTD (GB) | 2017-07-18 | — | — | US | disclosed |
| US-20160151324-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2016-06-02 | — | — | US | disclosed |
| EP-3021860-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | Leptrex Ltd. (GB) | 2016-05-25 | — | — | EP | disclosed |
| WO-2015008019-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2015-01-22 | — | — | WO | disclosed |
| WO-2014009759-A2 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2014-01-16 | — | — | WO | disclosed |
| EP-1901701-A2 | PERSONAL CARE AND MEDICINAL PRODUCTS INCORPORATING BOUND ORGANOSULFUR GROUPS | Ott, David M. (US) | 2008-03-26 | — | — | EP | disclosed |
| WO-2006127918-A2 | PERSONAL CARE AND MEDICINAL PRODUCTS INCORPORATING BOUND ORGANOSULFUR GROUPS | OTT DAVID M (US) | 2006-11-30 | — | — | WO | disclosed |
| WO-2003075901-A2 | USE OF S-SUBSTITUTED L-CRYSTEINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | GHISALBERTI CARLO (BR) | 2003-09-18 | — | — | WO | disclosed |